Carbamazepine-Induced Nonepileptic Myoclonus in a Child with Autism and Epilepsy

dc.contributor.authorKirik, Serkan
dc.contributor.authorYis, Uluc
dc.date.accessioned2026-08-12T16:59:06Z
dc.date.issued2021
dc.departmentFırat Üniversitesi
dc.description.abstractThis study deals with a child with different type of seizures several times in week and unresponsive to antiepileptic drugs. Distinguishing between epileptic seizure and motor tic in a patient diagnosed with epilepsy and autism can be challenging. In this study we present a boy on carbamazepine (CBZ) therapy. In the first days of treatment seizure frequency decreased, but after CBZ treatment dosage reached 15mg/kg/day (at the 25th day of the treatment), he presented to the clinic describing several episodes of myoclonus. There were no changes in electroencephalography during the myoclonus. In follow-up, myoclonus was not described after the cessation of CBZ.
dc.identifier.doi10.1055/s-0040-1721731
dc.identifier.endpage123
dc.identifier.issn2146-457X
dc.identifier.issn2146-4588
dc.identifier.issue3
dc.identifier.orcid0000-0002-8658-2448
dc.identifier.startpage121
dc.identifier.urihttps://doi.org/10.1055/s-0040-1721731
dc.identifier.urihttps://hdl.handle.net/11508/47182
dc.identifier.volume10
dc.identifier.wosWOS:000609097000001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherGeorg Thieme Verlag Kg
dc.relation.ispartofJournal of Pediatric Epilepsy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectmyoclonus
dc.subjectcarbamazepine
dc.subjectchild
dc.titleCarbamazepine-Induced Nonepileptic Myoclonus in a Child with Autism and Epilepsy
dc.typeArticle

Dosyalar